313 related articles for article (PubMed ID: 22275320)
1. Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease.
Murdoch TB; Xu W; Stempak JM; Landers C; Targan SR; Rotter JI; Silverberg MS
Inflamm Bowel Dis; 2012 Sep; 18(9):1743-8. PubMed ID: 22275320
[TBL] [Abstract][Full Text] [Related]
2. NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.
Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Chrousos G; Anagnou NP; Roma-Giannikou E
World J Gastroenterol; 2010 Apr; 16(14):1753-8. PubMed ID: 20380008
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.
Schoepfer AM; Schaffer T; Mueller S; Flogerzi B; Vassella E; Seibold-Schmid B; Seibold F
Inflamm Bowel Dis; 2009 Sep; 15(9):1358-67. PubMed ID: 19253375
[TBL] [Abstract][Full Text] [Related]
4. CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population.
Baptista ML; Amarante H; Picheth G; Sdepanian VL; Peterson N; Babasukumar U; Lima HC; Kugathasan S
Inflamm Bowel Dis; 2008 May; 14(5):674-9. PubMed ID: 18200510
[TBL] [Abstract][Full Text] [Related]
5. Variants of NOD1 and NOD2 genes display opposite associations with familial risk of Crohn's disease and anti-saccharomyces cerevisiae antibody levels.
Vasseur F; Sendid B; Jouault T; Standaert-Vitse A; Dubuquoy L; Francois N; Gower-Rousseau C; Desreumaux P; Broly F; Vermeire S; Colombel JF; Poulain D
Inflamm Bowel Dis; 2012 Mar; 18(3):430-8. PubMed ID: 21739538
[TBL] [Abstract][Full Text] [Related]
6. IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes.
Lauriola M; Ugolini G; Rivetti S; Nanì S; Rosati G; Zanotti S; Montroni I; Manaresi A; Zattoni D; Belluzzi A; Castellani L; D'Uva G; Mattei G; Taffurelli M; Strippoli P; Solmi R
Int J Mol Med; 2011 Mar; 27(3):469-77. PubMed ID: 21206965
[TBL] [Abstract][Full Text] [Related]
7. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.
Papadakis KA; Yang H; Ippoliti A; Mei L; Elson CO; Hershberg RM; Vasiliauskas EA; Fleshner PR; Abreu MT; Taylor K; Landers CJ; Rotter JI; Targan SR
Inflamm Bowel Dis; 2007 May; 13(5):524-30. PubMed ID: 17260364
[TBL] [Abstract][Full Text] [Related]
8. Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population-based cohort.
Ryan JD; Silverberg MS; Xu W; Graff LA; Targownik LE; Walker JR; Carr R; Clara I; Miller N; Rogala L; Bernstein CN
Aliment Pharmacol Ther; 2013 Aug; 38(3):274-83. PubMed ID: 23725363
[TBL] [Abstract][Full Text] [Related]
9. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.
Papp M; Altorjay I; Norman GL; Shums Z; Palatka K; Vitalis Z; Foldi I; Lakos G; Tumpek J; Udvardy ML; Harsfalvi J; Fischer S; Lakatos L; Kovacs A; Bene L; Molnar T; Tulassay Z; Miheller P; Veres G; Papp J; ; Lakatos PL
Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801
[TBL] [Abstract][Full Text] [Related]
10. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
Amcoff K; Joossens M; Pierik MJ; Jonkers D; Bohr J; Joossens S; Romberg-Camps M; Nyhlin N; Wickbom A; Rutgeerts PJ; Tysk C; Bodin L; Colombel JF; Vermeire S; Halfvarson J
J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
[TBL] [Abstract][Full Text] [Related]
11. NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans.
Dassopoulos T; Nguyen GC; Talor MV; Datta LW; Isaacs KL; Lewis JD; Gold MS; Valentine JF; Smoot DT; Harris ML; Oliva-Hemker M; Bayless TM; ; Burek CL; Brant SR
Am J Gastroenterol; 2010 Feb; 105(2):378-86. PubMed ID: 19826411
[TBL] [Abstract][Full Text] [Related]
12. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
Arnott ID; Landers CJ; Nimmo EJ; Drummond HE; Smith BK; Targan SR; Satsangi J
Am J Gastroenterol; 2004 Dec; 99(12):2376-84. PubMed ID: 15571586
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients.
Csöngei V; Járomi L; Sáfrány E; Sipeky C; Magyari L; Faragó B; Bene J; Polgár N; Lakner L; Sarlós P; Varga M; Melegh B
World J Gastroenterol; 2010 Jan; 16(2):176-83. PubMed ID: 20066736
[TBL] [Abstract][Full Text] [Related]
14. Genotype-Serotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases.
Ben-Shachar S; Finezilber Y; Elad H; Rabinowitz K; Goren I; Isakov O; Yanai H; Dotan I
Inflamm Bowel Dis; 2019 Jan; 25(2):336-344. PubMed ID: 30265311
[TBL] [Abstract][Full Text] [Related]
15. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis.
Homer CR; Richmond AL; Rebert NA; Achkar JP; McDonald C
Gastroenterology; 2010 Nov; 139(5):1630-41, 1641.e1-2. PubMed ID: 20637199
[TBL] [Abstract][Full Text] [Related]
16. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
17. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.
Mow WS; Vasiliauskas EA; Lin YC; Fleshner PR; Papadakis KA; Taylor KD; Landers CJ; Abreu-Martin MT; Rotter JI; Yang H; Targan SR
Gastroenterology; 2004 Feb; 126(2):414-24. PubMed ID: 14762777
[TBL] [Abstract][Full Text] [Related]
18. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J
Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
[TBL] [Abstract][Full Text] [Related]
19. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.
Devlin SM; Yang H; Ippoliti A; Taylor KD; Landers CJ; Su X; Abreu MT; Papadakis KA; Vasiliauskas EA; Melmed GY; Fleshner PR; Mei L; Rotter JI; Targan SR
Gastroenterology; 2007 Feb; 132(2):576-86. PubMed ID: 17258734
[TBL] [Abstract][Full Text] [Related]
20. Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease.
Gutiérrez A; Scharl M; Sempere L; Holler E; Zapater P; Almenta I; González-Navajas JM; Such J; Wiest R; Rogler G; Francés R
Gut; 2014 Feb; 63(2):272-80. PubMed ID: 23376290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
